GlassScriptPhysician profile
Stacey Wilson
NPI 1730582701
$2,741.59
in general payments reported to CMS, 2019-2025
40 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $674 · 2022: $1,644 · 2023: $131 · 2024: $17.50 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $343 · Education: $80.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $343.25 |
| Education | $80.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $225.46 | 2021-2025 | |
| Eisai INC. | $212.76 | 2021-2022 | |
| Janssen Biotech, INC. | $196.35 | 2021-2024 | Erleada, Akeega, Imbruvica |
| Merck Sharp & Dohme LLC | $179.75 | 2022 | |
| Novartis Pharmaceuticals Corporation | $178.48 | 2021-2023 | |
| Seagen INC. | $156.87 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $126.73 | 2021-2022 | |
| Ipsen Biopharmaceuticals, INC | $126.11 | 2021-2022 | |
| Incyte Corporation | $115.66 | 2021-2022 | |
| Acacia Pharma INC | $110.06 | 2022 | |
| Celgene Corporation | $89.53 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $88.83 | 2021-2022 | |
| Pfizer INC. | $84.55 | 2021-2022 | |
| Lilly USA, LLC | $77.17 | 2021-2022 | |
| Sobi, INC | $68.38 | 2022 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.